The Evolution of a Life Science Board
Tom Murphy Senior Vice President Bench International How would you characterize the evolution of a corporate board of directors? Startup companies typically have the founder and ea
What's New
Bench executive search delivers transformational executive talent to Biotech and Life Sciences companies of all sizes.
Recent Key Placement: Vice President and Head of Discovery Biology
Recent Key Placement: Vice President and Head of Discovery Biology – Blueprint Medicines – If you’re seeking to diversify your leadership team, or your board with hig
Why Life Science Executive Recruitment Firms Fail Their Clients – A View from Across the Pond
Natasha Allen Global SVP & Europe Region Head Bench International Why Life Science Executive Recruitment Firms Fail Their Clients – A View from Across the Pond Let’s start
Trends in Finding the Unfindable in Life Sciences Recruitment: An Interview with DeeDee DeMan
DeeDee DeMan Founder, Chairman & Chief Executive Officer Bench International What are most significant recruiting shifts that you have seen in Life Sciences executive search ov
Recent Key Placement: Brent Warner as President, Gene Therapy
Bench International is pleased to announce the successful completion of the appointment of Brent Warner as President, Gene Therapy at Poseida Therapeutics. Read the Poseida Ther
Recent Key Placement: Scott Shively as President and Chief Executive Officer, and member of the board of directors
Bench International is pleased to announce the successful completion of the appointment of Scott Shively as President and Chief Executive Officer, and member of the board of direc
Recent Key Placement: Vice President, Medical Affairs, Specimen Management at BD
Recent Key Placement: Vice President, Medical Affairs, Specimen Management – BD – If you’re seeking to diversify your leadership team, or your board with high impact
Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs
Cardiff Oncology Appoints Tod Smeal, Ph.D., as Chief Scientific Officer and Charles Monahan, RPh, as Senior Vice President, Regulatory Affairs Posted by Tom Murphy: The team at Ben
Recent Key Placement: David Eberhard MD, PhD as Chief Medical Officer
Recent Key Placement: David Eberhard MD, PhD as Chief Medical Officer – Inivata Liquid Biopsy a NeoGenomics, Inc. Subsidiary – If you’re seeking to diversify your leaders